Skip to main content

Table 3 Demographic and baseline disease condition

From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Patient No.

Arm

Age (years)

Height (cm)

Weight (kg)

Smoking/Tobacco

No. of cigarettes/Chews

Revascularization details

Grade of disease*

S001

Placebo

35

161

56

Past tobacco chewer

6

Right transfemoral proximal & distal thromboembolectomy with proximal tibial artery

III6

S004

Placebo

37

165

67.2

Ex-Smoker

24

No

II4

S005

BM-MSC

40

171

70.2

Ex-Smoker

10

No

III5

S007

BM-MSC

43

169

65

Ex-Smoker

48

Bypass surgery in left femoral artery

II4

S008

Placebo

32

166

42

Ex-Smoker

24

No

III5

S009

BM-MSC

46

169

60

Ex-Smoker

24

No

III6

S010

BM-MSC

57

160

42

Ex-Smoker

48

Femoropopliteal bypass above the knee

II4

S102

Placebo

45

174

72

Ex-Smoker

25

Right common femoral artery to anterior tibial artery reversed Gsv bypass

III5

S104

BM-MSC

44

159

63

Smoker

45

No

III5

S106

Placebo

32

164

71

Ex-Smoker

23

No

III5

S301

Placebo

43

167

62

Ex-Smoker

4

No

III6

S302

BM-MSC

37

165

62

Ex-Smoker

20

No

III6

S303

BM-MSC

53

172

69

Ex-Smoker

20

No

II4

S304

Placebo

59

162

60

Ex-Smoker

15

No

III6

S305

Placebo

57

167

70

Ex-Smoker

15

Right popliteal artery exploration

II4

S306

BM-MSC

46

170

46

Ex-Smoker

20

No

III5

S307

Placebo

54

165

50

Ex-Smoker

50

Femoropopliteal artery bypass above knee

III5

S308

BM-MSC

41

157

50

Ex-Smoker

20

No

III5

S402

BM-MSC

60

170

55

Ex-Smoker

23

Femoro - popliteal bypass

III5

S403

Placebo

36

167

60

Ex-Smoker

5

No

III5

  1. *Grade of disease classified according to Rutherford criteria.